Lakefront Biotherapeutics rebrands from Galapagos as it seeks turnaround from Chicago office

Lakefront Biotherapeutics, formerly known as Galapagos, announced a rebranding effort aimed at reviving the company’s fortunes. The change reflects a strategic shift as the firm looks to reposition itself in the biotech landscape.

The company’s leadership has moved into a new 22nd‑floor office that overlooks the Chicago Riverwalk, placing the team in the heart of the city’s downtown district. The location is highlighted as a symbolic backdrop for the transformation.

Executives say the rebranding and new headquarters are intended to support a broader turnaround plan, though specific milestones or financial details were not disclosed.